The global vaccine adjuvants market is expected to reach USD 1.9 billion by 2030, according to the report. The market is anticipated to grow at a CAGR of 2.3% from 2023 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants. ![Global Vaccine Adjuvants Market]( "Global Vaccine Adjuvants Market")
Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.
Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.
Vaccine Adjuvants Market Report Highlights
- The vaccine adjuvants market is segmented based on type into an adjuvant emulsion, pathogen, particulate, combination, and others. The particulate segment held the largest market share in 2022.
- The infectious diseases segment accounted for the largest revenue share of 68.1% in 2022. This large share can be attributed to the gradually growing prevalence of infectious diseases, such as malaria, influenza, hepatitis A, B, & C, and others.
- The administration segment is categorized into oral, intradermal, intranasal, intramuscular, and others. Due to better immune specificity, the intramuscular segment accounted for the largest revenue share of 33.8% in 2022
- North America dominated the market and accounted for the largest revenue share of 41.7% in 2022. The factors contributing to the growth of the market in the North American region are a rise in investments for R&D of new therapeutics and an increase in fatal epidemic diseases.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. Administration type
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.1.1. Type
1.1.2. Application
1.1.3. Administration type
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Administration outlook
2.2.4. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Administration outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Vaccine Adjuvants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Vaccine Adjuvants Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Vaccine Adjuvants Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Vaccine Adjuvants: Type Estimates & Trend Analysis
4.1. Vaccine Adjuvants Market: Key Takeaways
4.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Pathogen
4.3.1. Pathogen market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Adjuvant emulsion
4.4.1. Adjuvant emulsion market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Particulate
4.5.1. Particulate market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Combination
4.6.1. Combination market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Pathogen
4.3.1. Pathogen market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Adjuvant emulsion
4.4.1. Adjuvant emulsion market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Particulate
4.5.1. Particulate market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Combination
4.6.1. Combination market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Vaccine Adjuvants: Application Estimates & Trend Analysis
5.1. Vaccine Adjuvants Market: Key Takeaways
5.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious diseases
5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cancer
5.4.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious diseases
5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cancer
5.4.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Vaccine Adjuvants: Administration Estimates & Trend Analysis
6.1. Vaccine Adjuvants Market: Key Takeaways
6.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Oral
6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Intradermal
6.4.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Intranasal
6.5.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Intramuscular
6.6.1. Intramuscular market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
6.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Oral
6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Intradermal
6.4.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Intranasal
6.5.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Intramuscular
6.6.1. Intramuscular market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Vaccine Adjuvants Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Vaccine Adjuvants Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.2. Vaccine Adjuvants Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. GSK
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Novartis/CSL
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Agenus
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Adjuvance
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Novavax
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. SPI Pharma
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Invivogen
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Avanti Polar Lipids
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Brentagg
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2. Market Participant Categorization
8.2.1. GSK
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Novartis/CSL
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Agenus
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Adjuvance
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Novavax
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. SPI Pharma
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Invivogen
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Avanti Polar Lipids
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Brentagg
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America Vaccine Adjuvants market, by type, 2018 - 2030 (USD Million)
Table 3 North America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 4 North America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 5 North America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 9 Canada vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 10 Canada vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 11 Canada vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 12 Europe vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 13 Europe vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 14 Europe vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 15 Europe vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 16 Germany vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 17 Germany vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 18 Germany vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 19 UK vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 20 UK vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 21 UK vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 22 France vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 23 France vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 24 France vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 25 Italy vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 26 Italy vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 27 Italy vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 28 Spain vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 29 Spain vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 30 Spain vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 31 Denmark vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 34 Sweden vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 37 Norway vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 38 Norway vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 39 Norway vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 40 Asia Pacific vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 44 Japan vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 45 Japan vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 46 Japan vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 47 China vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 48 China vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 49 China vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 50 India vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 51 India vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 52 India vaccine adjuvants market, by administration, (USD Million) 2018 - 2030
Table 53 Australia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 54 Australia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 55 Australia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 56 Thailand vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 57 Thailand vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 58 Thailand vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 59 South Korea vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 60 South Korea vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 61 South Korea vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 62 Latin America vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 65 Latin America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 69 Mexico vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 72 Argentina vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 85 UAE vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 86 UAE vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 87 UAE vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 88 Kuwait vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 2 North America Vaccine Adjuvants market, by type, 2018 - 2030 (USD Million)
Table 3 North America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 4 North America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 5 North America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 9 Canada vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 10 Canada vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 11 Canada vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 12 Europe vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 13 Europe vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 14 Europe vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 15 Europe vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 16 Germany vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 17 Germany vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 18 Germany vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 19 UK vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 20 UK vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 21 UK vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 22 France vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 23 France vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 24 France vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 25 Italy vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 26 Italy vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 27 Italy vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 28 Spain vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 29 Spain vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 30 Spain vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 31 Denmark vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 34 Sweden vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 37 Norway vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 38 Norway vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 39 Norway vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 40 Asia Pacific vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 44 Japan vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 45 Japan vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 46 Japan vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 47 China vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 48 China vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 49 China vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 50 India vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 51 India vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 52 India vaccine adjuvants market, by administration, (USD Million) 2018 - 2030
Table 53 Australia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 54 Australia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 55 Australia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 56 Thailand vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 57 Thailand vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 58 Thailand vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 59 South Korea vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 60 South Korea vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 61 South Korea vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 62 Latin America vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 65 Latin America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 69 Mexico vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 72 Argentina vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 85 UAE vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 86 UAE vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 87 UAE vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 88 Kuwait vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Vaccine adjuvants: Market outlook
Fig. 8 Vaccine adjuvants: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Vaccine adjuvants market driver impact
Fig. 14 Vaccine adjuvants market restraint impact
Fig. 15 Vaccine adjuvants market strategic initiatives analysis
Fig. 16 Vaccine adjuvants market: Type movement analysis
Fig. 17 Vaccine adjuvants market: Type outlook and key takeaways
Fig. 18 Pathogen market estimates and forecasts, 2018 - 2030
Fig. 19 Adjuvant emulsion market estimates and forecasts, 2018 - 2030
Fig. 20 Particulate market estimates and forecasts, 2018 - 2030
Fig. 21 Combination market estimates and forecasts, 2018 - 2030
Fig. 22 Others market estimates and forecasts, 2018 - 2030
Fig. 23 Vaccine adjuvants market: Application movement analysis
Fig. 24 Vaccine adjuvants market: Application outlook and key takeaways
Fig. 25 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 26 Cancer market estimates and forecasts, 2018 - 2030
Fig. 27 Others market estimates and forecasts, 2018 - 2030
Fig. 28 Vaccine adjuvants market: Administration movement analysis
Fig. 29 Vaccine adjuvants market: Administration outlook and key takeaways
Fig. 30 Oral market estimates and forecasts, 2018 - 2030
Fig. 31 Intradermal market estimates and forecasts, 2018 - 2030
Fig. 32 Intranasal market estimates and forecasts, 2018 - 2030
Fig. 33 Intramuscular market estimates and forecasts, 2018 - 203
Fig. 34 Others market estimates and forecasts, 2018 - 2030
Fig. 35 Global vaccine adjuvants market: Regional movement analysis
Fig. 36 Global vaccine adjuvants market: Regional outlook and key takeaways
Fig. 37 North America market estimates and forecasts, 2018 - 2030
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
Fig. 39 Canada market estimates and forecasts, 2018 - 2030
Fig. 40 Europe market estimates and forecasts, 2018 - 2030
Fig. 41 UK market estimates and forecasts, 2018 - 2030
Fig. 42 Germany market estimates and forecasts, 2018 - 2030
Fig. 43 France market estimates and forecasts, 2018 - 2030
Fig. 44 Italy market estimates and forecasts, 2018 - 2030
Fig. 45 Spain market estimates and forecasts, 2018 - 2030
Fig. 46 Denmark market estimates and forecasts, 2018 - 2030
Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
Fig. 48 Norway market estimates and forecasts, 2018 - 2030
Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 50 Japan market estimates and forecasts, 2018 - 2030
Fig. 51 China market estimates and forecasts, 2018 - 2030
Fig. 52 India market estimates and forecasts, 2018 - 2030
Fig. 53 Australia market estimates and forecasts, 2018 - 2030
Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 61 South Africa market estimates and forecasts, 2018 - 2030
Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 63 UAE market estimates and forecasts, 2018 - 2030
Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Vaccine adjuvants: Market outlook
Fig. 8 Vaccine adjuvants: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Vaccine adjuvants market driver impact
Fig. 14 Vaccine adjuvants market restraint impact
Fig. 15 Vaccine adjuvants market strategic initiatives analysis
Fig. 16 Vaccine adjuvants market: Type movement analysis
Fig. 17 Vaccine adjuvants market: Type outlook and key takeaways
Fig. 18 Pathogen market estimates and forecasts, 2018 - 2030
Fig. 19 Adjuvant emulsion market estimates and forecasts, 2018 - 2030
Fig. 20 Particulate market estimates and forecasts, 2018 - 2030
Fig. 21 Combination market estimates and forecasts, 2018 - 2030
Fig. 22 Others market estimates and forecasts, 2018 - 2030
Fig. 23 Vaccine adjuvants market: Application movement analysis
Fig. 24 Vaccine adjuvants market: Application outlook and key takeaways
Fig. 25 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 26 Cancer market estimates and forecasts, 2018 - 2030
Fig. 27 Others market estimates and forecasts, 2018 - 2030
Fig. 28 Vaccine adjuvants market: Administration movement analysis
Fig. 29 Vaccine adjuvants market: Administration outlook and key takeaways
Fig. 30 Oral market estimates and forecasts, 2018 - 2030
Fig. 31 Intradermal market estimates and forecasts, 2018 - 2030
Fig. 32 Intranasal market estimates and forecasts, 2018 - 2030
Fig. 33 Intramuscular market estimates and forecasts, 2018 - 203
Fig. 34 Others market estimates and forecasts, 2018 - 2030
Fig. 35 Global vaccine adjuvants market: Regional movement analysis
Fig. 36 Global vaccine adjuvants market: Regional outlook and key takeaways
Fig. 37 North America market estimates and forecasts, 2018 - 2030
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
Fig. 39 Canada market estimates and forecasts, 2018 - 2030
Fig. 40 Europe market estimates and forecasts, 2018 - 2030
Fig. 41 UK market estimates and forecasts, 2018 - 2030
Fig. 42 Germany market estimates and forecasts, 2018 - 2030
Fig. 43 France market estimates and forecasts, 2018 - 2030
Fig. 44 Italy market estimates and forecasts, 2018 - 2030
Fig. 45 Spain market estimates and forecasts, 2018 - 2030
Fig. 46 Denmark market estimates and forecasts, 2018 - 2030
Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
Fig. 48 Norway market estimates and forecasts, 2018 - 2030
Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 50 Japan market estimates and forecasts, 2018 - 2030
Fig. 51 China market estimates and forecasts, 2018 - 2030
Fig. 52 India market estimates and forecasts, 2018 - 2030
Fig. 53 Australia market estimates and forecasts, 2018 - 2030
Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 61 South Africa market estimates and forecasts, 2018 - 2030
Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 63 UAE market estimates and forecasts, 2018 - 2030
Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030
Companies Profiled
- GSK
- Novartis/CSL
- Agenus
- Adjuvance
- Novavax
- SPI Pharma
- Invivogen
- Avanti Polar Lipids
- Brentagg
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | November 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.62 Billion |
| Forecasted Market Value ( USD | $ 1.9 Billion |
| Compound Annual Growth Rate | 2.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
